Article · Volume 2, Issue 4 · pp. 307–308
Benfluorex withdrawal in France: Still be hiding somewhere in the world?
Irène Frachon1, Grégoire Gal1, Catherine Hill1, Christophe Leroyer1
- 1Christophe Leroyer Université Européenne de Bretagne, UBO, EA3878 (GETBO) [Downloaded free from http://www.jpharmacol.com on Wednesday, October 13, 2021, IP: 157.45.222.78].
Abstract
Bhattacharyya et al. have recently reviewed the evidences demonstrating the association between the development of valvular heart disease and the use of appetite suppressants, including fenfl uramine.[1] Among numerous epidemiological data, evidence for a dose-effect relationship as well as demonstration of the underlying mechanism trough involvement of 5HT2B serotonin strongly argue for fenfl uramine exposure as a causal factor for valvular heart disease
Keywords: Correspondence
The full text of this article is available as a PDF. Open the PDF.